Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Angion Biomedica Corp. - Common Stock (NQ: ANGN )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Jun 1, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Angion Biomedica Corp. - Common Stock

Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
From Angion Biomedica Corp.
Via GlobeNewswire
ANGN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Angion Biomedica Corp. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Sumo Logic (Nasdaq – SUMO), Angion Biomedica Corp (Nasdaq - ANGN), TravelCenters of America Inc. (Nasdaq - TA), IAA, Inc. (NYSE - IAA)
From Brodsky & Smith LLC
Via GlobeNewswire
ANGION BIOMEDICA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Angion Biomedica Corp - ANGN
From Kahn Swick & Foti, LLC
Via Business Wire
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Angion Biomedica Corp (Nasdaq - ANGN)
From Brodsky & Smith LLC
Via GlobeNewswire
ANGN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Angion Biomedica Corp. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
Elicio Therapeutics and Angion Enter into Definitive Merger Agreement
From Angion Biomedica Corp.
Via GlobeNewswire
Angion Receives Nasdaq Notice Regarding Minimum Bid Price Requirements
From Angion Biomedica Corp.
Via GlobeNewswire
Angion Announces Process to Explore Strategic Alternatives for Enhancing and Preserving Shareholder Value
From Angion Biomedica Corp.
Via GlobeNewswire
Vifor Pharma and Angion report topline results from phase-II GUARD trial of ANG-3777 in cardiac surgery associated acute kidney injury
From Vifor Pharma
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.